Moneycontrol
HomeNewsBusinessGo First hopes to restart operations in two weeks with 20 aircraft: Sources
Trending Topics

Go First hopes to restart operations in two weeks with 20 aircraft: Sources

Go First aims to operate around 1,200 flights a week and slowly increase operations while the ongoing legal battle with Pratt & Whitney ensues.

May 11, 2023 / 08:43 IST
Story continues below Advertisement

Go Air. Editorial credit: Yatrik Sheth / Shutterstock.com

Bankrupt domestic carrier Go First is hoping to return to Indian skies in the next two weeks, after the New Delhi bench of the National Company Law Tribunal (NCLT) on May 10 granted bankruptcy protection to the airline.

"The expectations are that none of Go First's aircraft will be taken away by lessors which will let the airline return to the skies in around two weeks at the earliest," a source aware of the ongoing discussions said.

Story continues below Advertisement

The source added that Go First is hoping the interim resolution professional,  Abhilash Lal of Alvarez & Marsal appointed by the NCLT on May 10, will help negotiate a treaty between the lessors and the airline that will help Go First restart operations.

Also Read: P&W says pursuing its own legal recourse against Go First's claims

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show